Hyperfine (HYPR) Cash from Investing Activities (2021 - 2026)
Hyperfine (HYPR) reported Cash from Investing Activities of -$242000.0 for Q1 2026, up 48.73% on a YoY basis from -$162712.3 in Q1 2025, and down 284.13% quarter-over-quarter from -$63000.0 in Q4 2025.
Hyperfine (HYPR) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Hyperfine has reported Cash from Investing Activities for 6 years, with the latest figure at -$242000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 48.73% year-over-year to -$242000.0; the trailing twelve-month figure through Mar 2026 stood at -$955000.0 (down 34.51% YoY), and the FY2025 full-year result was -$1.2 million, down 209.4% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$242000.0, down from -$63000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $54000.0 in Q2 2022, with the low at -$520000.0 in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$188176.5 across 5 years, with a median of -$159000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 110.69% — and 2025, when it tumbled 687.5%.
- Hyperfine's Cash from Investing Activities stood at -$158000.0 in 2022, then sank by 63.29% to -$258000.0 in 2023, then surged by 96.9% to -$8000.0 in 2024, then plunged by 687.5% to -$63000.0 in 2025, then slumped by 284.13% to -$242000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$242000.0 (Q1 2026), -$63000.0 (Q4 2025), and -$130000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | -242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -242,000.00 |
| Mar 31, 2026 | -242,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | -258,000.00 |
| Dec 31, 2023 | -258,000.00 |